Medicine

Wenqiang Zhou, Hui Zhu, Zhongquan Liu, W. Nie, Qingfeng Wang, Wenhui Shi, Yang Yang, Wenjie Qi, Yu Lu, Naihui Chu

2026.2.9PHARMACOTHERAPY

DOI: 10.1002/phar.70109

tlooto Summary

This time-dependent nomogram, integrating Cmin with baseline clinical factors, enables early identification of patients with DR-TB at high risk for hematotoxicity and could guide pre-emptive interventions.

Abstract

Linezolid is essential for drug‐resistant tuberculosis (DR‐TB) treatment but causes frequent hematological toxicity. We developed a time‐dependent nomogram to predict this risk.

Citation format

ZHOU, Wenqiang, et al. Development and validation of a time‐dependent nomogram for predicting hematological toxicity risk during linezolid therapy in drug‐resistant tuberculosis. PHARMACOTHERAPY, 2026, 46(3): e70109.